25 years of dividend hikes for this healthcare leader

December 3, 2018

Published by Harvest Exchange Traded Funds.

Quality is what thrives in good times and bad. When it comes to investments some of the things that indicate quality are established businesses with industry dominance, a history of rising profits and dividends that have grown over time.

Stryker Corp. (NYSE: SYK), a leader in the global medical device industry and is an example of that.

The company was founded in Michigan in 1941 by Dr. Homer Stryker who believed his patients needed better medical devices to improve their lives. Almost 80 years later, the company has three main products lines. The Orthopedics segment provides hip and knee implants. MedSurg offers surgical equipment, including surgical navigation systems, emergency medical equipment, and intensive care disposable products. The Neurotechnology and Spine segment provides products for brain and skull surgery, synthetic bone grafts and spinal implants.

Stryker has a market capitalization of US $65.5 billion, had sales of $US 12.4 billion in 2017 and employs more than 33,000 people. It continues to benefit from global trends in aging and the development of emerging market healthcare systems. Both are increasing demand for its products.

Stryker delivered another strong quarter in the three months ended Sept. 30, with all divisions delivering high levels of organic growth. This year it raised its dividend by 11% which is the 25th consecutive year of a dividend increase.  

On October 25, Stryker reported its third quarter financial results. The company earned $1.69 per share which topped estimates and was 11% better than the same quarter in 2017. Revenue grew 7.6% to $3.24 billion with all business units reporting higher sales.

One growing area for Stryker is the use of its robots in knee surgery. Studies have shown that the use of robots improves surgical precision, decreases pain and speeds up recovery time. The company has installed nearly six hundred robots worldwide and has provided training for  1,350 surgeons. The unit reportedly cost $1 million each.

Stryker is a top holding in the Harvest Portfolios Group  Harvest Healthcare Leaders Income ETF (HHL-T, HHL.U). The  ETF aims to capture growth in the healthcare sector. The Fund invests in the stocks of 20 healthcare companies with a minimum market capitalization of US$5 billion at the time of investment. – AM

For more on Harvest Portfolio Group ETFs click here.

You might like:

You may also like…


For Information Purposes Only. Commissions, management fees and expenses all may be associated with investing in HARVEST Exchange Traded Funds (managed by Harvest Portfolios Group Inc.) Please read the relevant prospectus before investing. The funds are not guaranteed, their values change frequently and past performance may not be repeated. This communication should not be considered as advice and/or a recommendation to purchase or sell the mentioned securities or used to engage in personal investment strategies. Tax, investment and all other decisions should be made with guidance from a qualified professional.

Certain statements in the Harvest Blog are forward looking Forward-looking statements (“FLS”) are statements that are predictive in nature, depend upon or refer to future events or conditions, or that include words such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “intend,” “plan,” “believe,” or  “estimate,” or other similar expressions. Statements that look forward in time or include anything other than historical information are subject to risks and uncertainties, and actual results, actions or events could differ materially from those set forth in the FLS.

FLS are not guarantees of future performance and are by their nature based on numerous assumptions, which include, amongst other things, that (i) the Fund can attract and maintain investors and have sufficient capital under management to effect their investment strategies, (ii) the investment strategies will produce the results intended by the portfolio managers, and (iii) the markets will react and perform in a manner consistent with the investment strategies. Although the FLS contained herein are based upon what the portfolio manager believe to be reasonable assumptions, the portfolio manager cannot assure that actual results will be consistent with these FLS.

Unless required by applicable law, Harvest Portfolios Group Inc. does not undertake, and specifically disclaim, any intention or obligation to update or revise any FLS, whether as a result of new information, future events or otherwise.

Sign up to receive our monthly updates